Cargando…

Breast Cancer Presenting As Onconeural Antibody Negative Opsoclonus-Myoclonus Syndrome

Breast cancer can rarely present with or be preceded by paraneoplastic syndromes such as opsoclonus-myoclonus syndrome (OMS). OMS is a rare neurological syndrome that commonly presents with symptoms of rapid, chaotic eye movements (opsoclonus), jerking involuntary muscle movements (myoclonus) and is...

Descripción completa

Detalles Bibliográficos
Autores principales: Soares, Ryan, Mittapalli, Amrutha, Ramakrishnan, Manju, Farooq, Umar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416628/
https://www.ncbi.nlm.nih.gov/pubmed/36046059
http://dx.doi.org/10.7759/cureus.28417
_version_ 1784776525012271104
author Soares, Ryan
Mittapalli, Amrutha
Ramakrishnan, Manju
Farooq, Umar
author_facet Soares, Ryan
Mittapalli, Amrutha
Ramakrishnan, Manju
Farooq, Umar
author_sort Soares, Ryan
collection PubMed
description Breast cancer can rarely present with or be preceded by paraneoplastic syndromes such as opsoclonus-myoclonus syndrome (OMS). OMS is a rare neurological syndrome that commonly presents with symptoms of rapid, chaotic eye movements (opsoclonus), jerking involuntary muscle movements (myoclonus) and is frequently associated with ataxia. We describe a case of a woman in her early 50s who presented to the emergency room (ER) with vertigo, jerking movements, loss of fine motor skills and gait abnormalities. She was initially thought to have likely vestibular neuritis and was treated symptomatically and discharged home. However, the symptoms persisted and she presented once again to the ER, at which time she also incidentally discovered a lump in her breast. This led to her being investigated more extensively leading to a diagnosis of underlying primary breast cancer. Based on her neurological clinical findings, she was diagnosed with onconeural antibody negative OMS. Treatment of her underlying malignancy led to a significant improvement in her symptoms. Paraneoplastic neurological syndromes (PNSs) are an important differential diagnosis to consider in patients presenting with persistent, treatment-resistant and non-specific neurological symptoms. Any suspicion of the same should prompt a search for an underlying malignancy that could greatly influence patient outcomes.
format Online
Article
Text
id pubmed-9416628
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-94166282022-08-30 Breast Cancer Presenting As Onconeural Antibody Negative Opsoclonus-Myoclonus Syndrome Soares, Ryan Mittapalli, Amrutha Ramakrishnan, Manju Farooq, Umar Cureus Internal Medicine Breast cancer can rarely present with or be preceded by paraneoplastic syndromes such as opsoclonus-myoclonus syndrome (OMS). OMS is a rare neurological syndrome that commonly presents with symptoms of rapid, chaotic eye movements (opsoclonus), jerking involuntary muscle movements (myoclonus) and is frequently associated with ataxia. We describe a case of a woman in her early 50s who presented to the emergency room (ER) with vertigo, jerking movements, loss of fine motor skills and gait abnormalities. She was initially thought to have likely vestibular neuritis and was treated symptomatically and discharged home. However, the symptoms persisted and she presented once again to the ER, at which time she also incidentally discovered a lump in her breast. This led to her being investigated more extensively leading to a diagnosis of underlying primary breast cancer. Based on her neurological clinical findings, she was diagnosed with onconeural antibody negative OMS. Treatment of her underlying malignancy led to a significant improvement in her symptoms. Paraneoplastic neurological syndromes (PNSs) are an important differential diagnosis to consider in patients presenting with persistent, treatment-resistant and non-specific neurological symptoms. Any suspicion of the same should prompt a search for an underlying malignancy that could greatly influence patient outcomes. Cureus 2022-08-25 /pmc/articles/PMC9416628/ /pubmed/36046059 http://dx.doi.org/10.7759/cureus.28417 Text en Copyright © 2022, Soares et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Soares, Ryan
Mittapalli, Amrutha
Ramakrishnan, Manju
Farooq, Umar
Breast Cancer Presenting As Onconeural Antibody Negative Opsoclonus-Myoclonus Syndrome
title Breast Cancer Presenting As Onconeural Antibody Negative Opsoclonus-Myoclonus Syndrome
title_full Breast Cancer Presenting As Onconeural Antibody Negative Opsoclonus-Myoclonus Syndrome
title_fullStr Breast Cancer Presenting As Onconeural Antibody Negative Opsoclonus-Myoclonus Syndrome
title_full_unstemmed Breast Cancer Presenting As Onconeural Antibody Negative Opsoclonus-Myoclonus Syndrome
title_short Breast Cancer Presenting As Onconeural Antibody Negative Opsoclonus-Myoclonus Syndrome
title_sort breast cancer presenting as onconeural antibody negative opsoclonus-myoclonus syndrome
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416628/
https://www.ncbi.nlm.nih.gov/pubmed/36046059
http://dx.doi.org/10.7759/cureus.28417
work_keys_str_mv AT soaresryan breastcancerpresentingasonconeuralantibodynegativeopsoclonusmyoclonussyndrome
AT mittapalliamrutha breastcancerpresentingasonconeuralantibodynegativeopsoclonusmyoclonussyndrome
AT ramakrishnanmanju breastcancerpresentingasonconeuralantibodynegativeopsoclonusmyoclonussyndrome
AT farooqumar breastcancerpresentingasonconeuralantibodynegativeopsoclonusmyoclonussyndrome